SEARCH BY NAME

BROWSE

Browse Australian delisted companies

0-9A BC DE F GH IJ KL MN OP QR ST UV WX YZ

Browse terminated Australian managed funds

0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

GENESIS RESEARCH AND DEVELOPMENT CORPORATION LIMITED (GEN)

Delisted from ASX 30/08/2013

SHARE PRICES

Former (or subsequent) names

 

Shareholder links

Our website ranking of GEN: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Computershare, Level 3, 60 Carrington Street, Sydney NSW 2000
Tel : +61 2 8234 5000
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details

Address: Level 15 PWC Tower, 188 Quay St Auckland, New Zealand
Tel:  +64 9 373 5600 Fax: +64 9 373 5601

Date first listed: 22/09/2000
Company Secretary: Stephen Hall
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Biotechnology company with core technical expertise in the fields of genomics and immunology - company seeks novel biologics which can be used as therapeutics or as targets for new drug therapies - primary disease targets are inflammatory or atopic disord
company deregistered today19/05/2015
delisted following non-payment of annual listing fees in respect of the year ending 30 June 201430/08/2013
we understand this company failed and has finally been delisted by ASX following non-payment of annual listing fees30/08/2013
The company has not paid its annual fees in respect of the year ending 30 June 2014 but are already suspended from official quotation. In accordance with listing rule 16.5, entities that pay their annual listing fees on or after 23 August 2013must pay by bank cheque only. Under listing rule 17.15, any entity that has not paid its annual listing fees as required by listing rule 16.5 by 5.00 pm EST on Thursday 29 August 2013 will be removed from the official list with effect from the close of trading on Thursday 29 August 2013.23/08/2013
releases Preliminary Final Report01/03/2013
The securities of Genesis Research and Development Corporation Limited (the "Company") will be suspended from quotation immediately, under listing rule 17.3, following the Company" announcement today that it ""¦has insufficient funds to continue, even as a as a non-operating investment entity". Security Code: GEN13/11/2012
the suspension of trading in the securities of Genesis Research and Development Corporation Limited (the "Company") will be lifted before the commencement of trading on Monday, 5 September 2011 in accordance with listing rule 17.8, following lodgement of the Company's Half Year Accounts for the period ended 30 June 201102/09/2011
suspended from quotation following failure to lodge financial reports01/09/2011

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Aki von RoyChairman
    Joachim von RoyChairman, Independent Director
    Stephen HallCEO17/12/2004
    Ewe LimCFO
    Andy GearingIndependent Director26/01/2006
    Steven GillisIndependent Director
    Daniel Mahnert-LuegIndependent Director
    Gude BuerDirector19/12/2012
    Phi San LamDirector09/08/2013
    Frankie ChenDirector09/08/2013
    Sharon KwanDirector09/08/2013

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Catherine YanDirector12/07/201225/01/2013
    Tina TanDirector30/11/201206/12/2012

    Date of first appointment, title may have changed.